HYPR

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 6

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,437

Underlying: Class A Common Stock · 237,437 shares

Expires 2031-04-27

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 5

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 237,437 shares

Expires 2031-04-27

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a "SPAC transaction") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal ("IPO") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 4

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 712,312

Underlying: Class A Common Stock · 712,312 shares

Expires 2031-04-27

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 3

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 712,312 shares

Expires 2031-04-27

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 2

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,437

Underlying: Class A Common Stock · 237,437 shares

Expires 2032-03-29

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

SEC source: 0001209191-22-055106 · doc4.xml · derivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 237,437 shares

Expires 2032-03-29

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

SEC source: 0001209191-22-046007 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 543,858

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-046116 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,119

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-046104 · doc4.xml · nonDerivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,067

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-046113 · doc4.xml · nonDerivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,296

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-045707 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479,645

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-041114 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,154

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-041106 · doc4.xml · nonDerivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,958

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-036999 · doc4.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,508

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.3498, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

SEC source: 0001209191-22-036274 · doc4.xml · derivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Rothberg's continued service through the applicable vesting date.

SEC source: 0001209191-22-036280 · doc4.xml · derivative · entry 1

Sainz Maria · CIK 0001437768 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Sainz's continued service through the applicable vesting date.

SEC source: 0001209191-22-036279 · doc4.xml · derivative · entry 1

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

SEC source: 0001209191-22-036275 · doc4.xml · derivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huenneken's continued service through the applicable vesting date.

SEC source: 0001209191-22-036277 · doc4.xml · derivative · entry 1

Dahldorf John T · CIK 0001365494 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.

SEC source: 0001209191-22-036281 · doc4.xml · derivative · entry 1

Wolterman Dan · CIK 0001586330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,345

Underlying: Class A Common Stock · 85,345 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

SEC source: 0000899243-22-015867 · doc4.xml · nonDerivative · entry 1

Scott David D · CIK 0001899784 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 799,350

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon payment. The RSUs will be paid in four equal installments on February 15, 2023, May 15, 2023, August 15, 2023 and November 15, 2023, unless Mr. Scott is terminated for cause prior to the applicable payment date, and subject to acceleration upon a change in control of the issuer.

SEC source: 0001104659-22-041199 · tm2211004-2_4seq1.xml · derivative · entry 3

Scott David D · CIK 0001899784 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 474,875

Underlying: Class A Common Stock · 474,875 shares

Expires 2032-03-29

F3 · derivative.exercise_date: The shares underlying this option vest in full on March 29, 2027, subject to Mr. Scott's continued service through the vesting date.

SEC source: 0001104659-22-041199 · tm2211004-2_4seq1.xml · derivative · entry 2

Scott David D · CIK 0001899784 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Class A Common Stock · 300,000 shares

Expires 2032-03-29

F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments beginning on April 29, 2022, subject to Mr. Scott's continued service through the applicable vesting dates.

SEC source: 0001104659-22-041199 · tm2211004-2_4seq1.xml · nonDerivative · entry 1

Scott David D · CIK 0001899784 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over four years beginning on March 29, 2023, subject to Mr. Scott's continued service through the applicable vesting dates.

SEC source: 0001104659-22-041200 · tm2211004-3_4seq1.xml · nonDerivative · entry 2

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,000

F2 · shares: The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-041200 · tm2211004-3_4seq1.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

F1 · shares: The shares underlying this restricted stock unit ("RSU") vest as to 25% on the grant date, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning February 15, 2021; provided that any vesting of the award will be delayed until July 1, 2022, and the number of RSUs vesting on the first scheduled vesting date following July 1, 2022 will also include any delayed vesting RSUs, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-041201 · tm2211004-4_4seq1.xml · nonDerivative · entry 2

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,500

F2 · shares: The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001104659-22-041201 · tm2211004-4_4seq1.xml · nonDerivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

F1 · shares: The shares underlying this restricted stock unit ("RSU") vest as to 25% on May 1, 2022, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years beginning May 15, 2022; provided that any vesting of the award will be delayed until July 1, 2022, and the number of RSUs vesting on the first scheduled vesting date following July 1, 2022 will also include any delayed vesting RSUs, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001104659-22-041198 · tm2211004-1_4seq1.xml · nonDerivative · entry 2

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,167

F2 · shares: The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001104659-22-041198 · tm2211004-1_4seq1.xml · nonDerivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: The shares underlying this restricted stock unit ("RSU") vest as to 25% on August 16, 2022, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning August 15, 2022, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001104659-22-041203 · tm2211004-6_4seq1.xml · derivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,437

Underlying: Class A Common Stock · 237,437 shares

Expires 2032-03-29

F1 · derivative.exercise_date: The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date.

SEC source: 0001104659-22-041202 · tm2211004-5_4seq1.xml · nonDerivative · entry 2

White Scott A. · CIK 0001899897 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,875

F2 · shares: The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Mr. White's continued service through the applicable vesting date.

SEC source: 0001104659-22-041202 · tm2211004-5_4seq1.xml · nonDerivative · entry 1

White Scott A. · CIK 0001899897 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The shares underlying this restricted stock unit ("RSU") vest as to 25% on September 27, 2022, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning August 15, 2022, subject to Mr. White's continued service through the applicable vesting date.

SEC source: 0000899243-22-010325 · doc4.xml · derivative · entry 1

Fattori Ruth A · CIK 0001306826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2032-03-08

SEC source: 0001104659-22-020844 · tm226447-3_4seq1.xml · derivative · entry 2

Siddiqui Khan · CIK 0001898560 · Chief Medical Officer and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-020844 · tm226447-3_4seq1.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · Chief Medical Officer and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on the date of grant, and 2.083% at the end of each month thereafter beginning on February 31, 2022, subject to Dr. Siddiqui's continued service through the applicable vesting date; provided that any vesting of the award will be delayed if as of the applicable vesting date a registration statement on Form S-8 registering shares under the registrant's 2021 Equity Incentive Plan has not yet been filed with the Securities and Exchange Commission, and in such event the number of options vesting on the first scheduled vesting date following the filing of the registration statement will also include any delayed vesting options.

SEC source: 0001104659-22-020800 · tm226447-1_4seq1.xml · derivative · entry 1

Hughes Mark A. · CIK 0001898765 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Class A Common Stock · 45,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Hughes's continued service through the applicable vesting date.

SEC source: 0001104659-22-020802 · tm226447-4_4seq1.xml · derivative · entry 2

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2032-02-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001104659-22-020802 · tm226447-4_4seq1.xml · derivative · entry 1

Paykel Neela · CIK 0001894593 · Gen Counsel & Corp Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,750

Underlying: Class A Common Stock · 71,750 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on May 1, 2022, and 2.083% at the end of each month thereafter beginning on June 30, 2022, subject to Ms. Paykel's continued service through the applicable vesting date.

SEC source: 0001104659-22-020801 · tm226447-2_4seq1.xml · derivative · entry 2

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,333

Underlying: Class A Common Stock · 54,333 shares

Expires 2032-02-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001104659-22-020801 · tm226447-2_4seq1.xml · derivative · entry 1

Gupta Alok · CIK 0001894388 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Class A Common Stock · 200,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on August 16, 2022 and 2.083% at the end of each month thereafter beginning on September 30, 2022, subject to Mr. Gupta's continued service through the applicable vesting date.

SEC source: 0001104659-22-020804 · tm226447-5_4seq1.xml · derivative · entry 2

White Scott A. · CIK 0001899897 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Class A Common Stock · 43,750 shares

Expires 2032-02-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Mr. White's continued service through the applicable vesting date.

SEC source: 0001104659-22-020804 · tm226447-5_4seq1.xml · derivative · entry 1

White Scott A. · CIK 0001899897 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Class A Common Stock · 150,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on September 27, 2022, and 2.083% at the end of each month thereafter beginning on October 31, 2022, subject to Mr. White's continued service through the applicable vesting date.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 8

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,250,000

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 7

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,228,053

F6 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive.

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 6

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,150,000

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 5

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,125,000

F5 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive.

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 4

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,116,590

F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive.

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 3

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,113,677

F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4.

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

SEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 2

HC Sponsor LLC · CIK 0001833772 · 10% owner

HealthCor Group, LLC · CIK 0001409307 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,100,000

F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

F2 · ownership.nature: Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities.